Efficacy and safety of rituximab biosimilar in refractory lupus

AIMS: To characterise patients with refractory SLE receiving rituximab biosimilar (CT-P10) and to explore short-term efficacy and safety associated with rituximab biosimilar use. METHODS: We retrospectively analysed data from the medical records of patients with refractory SLE who received CT-P10 in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Lupus Sci Med
Main Authors: Pongtarakulpanit, Nantakarn, Pisitkun, Prapaporn, Ngamjanyaporn, Pintip
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2020
Fag:
Brief Communication
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7607610/
https://ncbi.nlm.nih.gov/pubmed/33139454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/lupus-2020-000442
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker